1. Home
  2. ENTA vs CARE Comparison

ENTA vs CARE Comparison

Compare ENTA & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.04

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$21.66

Market Cap

438.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
CARE
Founded
1995
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
438.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
CARE
Price
$14.04
$21.66
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
220.0K
147.3K
Earning Date
02-09-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.19
EPS
N/A
1.38
Revenue
$66,980,000.00
$157,055,000.00
Revenue This Year
$0.99
$15.14
Revenue Next Year
$0.19
$9.25
P/E Ratio
N/A
$15.72
Revenue Growth
0.58
11.49
52 Week Low
$4.09
$13.61
52 Week High
$17.15
$22.51

Technical Indicators

Market Signals
Indicator
ENTA
CARE
Relative Strength Index (RSI) 55.34 60.86
Support Level $13.18 $21.95
Resistance Level $15.55 $22.37
Average True Range (ATR) 0.66 0.58
MACD 0.17 0.01
Stochastic Oscillator 50.00 67.55

Price Performance

Historical Comparison
ENTA
CARE

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: